Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    2 top FTSE 100 stocks that are outperforming the market

    | Stuart Blair

    While the FTSE 100 has lagged other global indexes, these two FTSE 100 stocks have performed excellently. Can their strength…

    Read more »

    Newspaper and direction sign with investment options
    Investing Articles

    The UK economy slows down — 2 FTSE 100 growth stocks I’d buy

    | Manika Premsingh

    The UK economy could slow down now, as evident from the latest growth numbers. But not all FTSE 100 stocks…

    Read more »

    Investing Articles

    1 FTSE 100 stock I’d buy to beat inflation as it rises to 6.2%!

    | Manika Premsingh

    As inflation rises, Manika Premsingh believes this FTSE 100 stock could be among her best investments. 

    Read more »

    Investing Articles

    2 reasons I’m buying at the current AstraZeneca share price

    | Andrew Woods

    With strong historical results and a number of drugs in development, does the AstraZeneca share price now make the stock…

    Read more »

    Investing Articles

    2 FTSE 100 shares to buy before the 5 April ISA deadline

    | Kevin Godbold

    Here are two FTSE 100 shares to buy now that I'm keen to add to my diversified stocks portfolio to…

    Read more »

    Investing Articles

    This FTSE 100 stock would’ve tripled my money in 10 years. Can it happen again?

    | Manika Premsingh

    Manika Premsingh holds this FTSE 100 stock in her portfolio already, but is now wondering if it is likely to…

    Read more »

    happy senior couple using a laptop in their living room to look at their financial budgets
    Investing Articles

    How I’d invest £1,000 in my Stocks and Shares ISA before the April deadline

    | Jon Smith

    Jon Smith explains which stocks he'd buy now before the Stocks and Shares ISA deadline, based on dividend and growth…

    Read more »

    A graph made of neon tubes in a room
    Investing Articles

    AstraZeneca shares jump 5% today; I think they could go higher still this year

    | Jon Smith

    Jon Smith notes the jump in the AstraZeneca share price today and thinks that there's room for it to run…

    Read more »

    Middle age senior woman sitting at the table at home working using computer laptop clueless and confused expression with arms and hands raised.
    Investing Articles

    Worried about a stock market crash? 2 FTSE 100 shares I’d consider buying anyway

    | Charlie Carman

    A stock market crash could be on the horizon. As a long-term investor, I continue to look for shares in…

    Read more »

    Investing Articles

    3 FTSE 100 stocks I’d buy with £20,000 now for the next 10 years

    | Manika Premsingh

    These FTSE 100 stocks are all part of Manika Premsingh’s portfolio, each bringing with them their unique long-term growth story. 

    Read more »

    Investing Articles

    3 FTSE 100 stocks I’d buy for growth in 2022

    | Roland Head

    FTSE 100 stocks can be fast growers too. Roland Head looks at three heavyweights with big growth forecasts, including an…

    Read more »

    Elevated view over city of London skyline
    Investing Articles

    3 UK shares to buy today with £3k

    | Rupert Hargreaves

    Rupert Hargreaves takes a look at the three UK shares he would acquire for his portfolio today as uncertainty grows.

    Read more »